← Back to Search

Epidural Analgesia Techniques for Labor Pain

N/A
Recruiting
Led By Geneviève Rivard, Dr.
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pregnant nulliparous or multiparous woman in labour
Obtained consent for epidural analgesia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial will compare two methods of labor pain relief to see if one uses less medication.

Who is the study for?
This trial is for pregnant women in labor, whether it's their first child or not. They must be at least 18 years old and have agreed to epidural pain relief. Their overall health should be good to moderately impaired (ASA I-III), and they need to be in early labor with a cervical dilation of 6cm or less.Check my eligibility
What is being tested?
The study is testing two methods of delivering pain medication through an epidural during labor: one group will receive the drug bupivacaine continuously, while the other will get programmed intermittent doses plus control over additional dosing as needed.See study design
What are the potential side effects?
Epidural analgesia can cause side effects such as low blood pressure, backache, headache, or temporary soreness where the needle enters. Rarely, more serious complications like nerve damage may occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am pregnant and in labor, regardless of how many times I've been pregnant before.
Select...
I have agreed to receive pain relief through an epidural.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dose of bupivacaine in milligrams per hour
Secondary outcome measures
Anesthesiologist manual bolus
Assisted vaginal delivery
Cesarean section
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Study groupExperimental Treatment1 Intervention
Programmed intermittent epidural bolus + patient controlled analgesia
Group II: Control groupActive Control1 Intervention
Continuous infusion + patient controlled epidural analgesia

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
290 Previous Clinical Trials
68,745 Total Patients Enrolled
Geneviève Rivard, Dr.Principal InvestigatorUniversité de Sherbrooke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is recruitment for this clinical study progressing?

"Affirmative. According to information on clinicaltrials.gov, this trial is searching for patients and was first posted online in June 2019 with the most recent update being May 2022. 200 individuals are sought from a single site of recruitment."

Answered by AI

Are positions still available for prospective participants in this research?

"Per the information on clinicaltrials.gov, this study is actively seeking participants since it was first published in June 2019 and most recently updated in May 2022."

Answered by AI
Recent research and studies
~42 spots leftby Jun 2025